Bibliography

Autoimmune Disease and Arthritis

2017

Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs. (2017) McArdle A, Pennington S, FitzGerald O Clin Rev Allergy Immunol.
 
 

Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs (2017) McArdle A, Pennington S, FitzGerald O Clin Rev Allergy Immunol
 
 

Altered Expression of MicroRNAs in Rheumatoid Arthritis (2017) Tavasolian E, Abdollahi E, Rezaei R, Momtazi AA, Henrotin Y, Sahebkar A J. Cell. Biochem.
 
 

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis after Methotrexate Failure (2017) Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF Arthritis Rheumatol
 
 

A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study (2017) Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han K.H, Ronday H.K, Bolce R, Sasso E, Kerstens P, Lems WF, Huizinga T, and Allaart CF J Rheumatol.
 
 

Proteomics to predict the response to tumour necrosis factor-a inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score (2017) Cuppen BVJ, Fritsch-Stork RDE, Eekhout, W de Jager I, Marijnissen AC, Bijlsma JWJ, Custers M, Van Laar JM, Lafeber FPJG, Welsing PMJ & on behalf of all Society for Rheumatology Research Utrecht (SRU) investigators Scand J Rheumatol
 
 

Back To Top

2016

Type I Ifns Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-Versus-Host Disease (2016) Delaney TA, Morehouse C, Brohawn PZ, Groves C, Colonna M, Yao, Y, Sanjuan M, Coyle AJ The Journal of Immunology
 
 

Biomarkers in Rheumatoid Arthritis, what is new? (2016) Gavrila BI, Ciofu C, and Stoica V J Med Life
 
 

Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice (2016) Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y Mod Rheumatol
 
 

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial (2016) Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso E, Chernoff D and Van Vollenhoven R RMD
 
 

Sjögren’s Syndrome Patients with Ectopic Germinal Centers Present with a Distinct Salivary Proteome (2016) Delaleu N, Mydel P, Brun JG, Jonsson MV, Alimonti A, Jonsson R Rheumatology

Vagus Nerve Stimulation Inhibits Cytokine Production and Attenuates Disease Severity in Rheumatoid Arthritis (2016) Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, Mehta AD, Levine YA, Faltys M, Zitnik R, Tracey KJ, Tak PP PNAS

Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study (2016) Inman RD, Baraliakos X, Hermann KA, Braun J, Deodhar A, Heijde D, Xu S, and Hsu B Arthritis Res Ther.
 
 

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis (2016) Rovin B, van Vollenhoven R, Aranow C, Wagner C, Gordon R, Zhuang Y, Belkowski S, Hsu B Arthritis & Rheumatology

Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children (2016) Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, Ledford JG, Marques Dos Santos M, Anderson RL, Metwali N, Neilson JW, Maier RM, Gilbert JA, Holbreich M, Thorne PS, Martinez FD, Von Mutius E, Vercelli D, Ober C, Sperling AI New England Journal of Medicine

Back To Top

2015

Self-reactive IgE exacerbates interferon responses associated with autoimmunity (2015) Henault J, Riggs JM, Karnell JL, Liarski VM, Li J, Shirinian L, Xu L, Casey KA, Smith MA, Khatry DB, Izhak L, Clarke L, Herbst R, Ettinger R, Petri M, Clark MR, Mustelin T, Kolbeck R, Sanjuan MA Nat Immunol.

Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model. (2015) Atkinson SM, Nansen A, Usher PA, Sondergaard BC, Mackay CR, Friedrichsen B, Chang CC, Tang R, Skov S, Haase C, Hornum L. Autoimmunity. 2015 Apr 27:1-11. [Epub ahead of print]

Markers of atherosclerosis in relation to presence and progression of knee osteoarthritis: a population-based cohort study. (2015) Hoeven TA, Kavousi M, Ikram AM, van Meurs JB, Bindels PJ, Hofman A, Franco OH, Bierma-Zeinstra SM. Rheumatology (Oxford). 2015 May 6. pii: kev106. [Epub ahead of print]

Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles. (2015) Selvaraj V, Nepal N1, Rogers S, Manne ND, Arvapalli R, Rice KM, Asano S, Fankhanel E, Ma JJ, Shokuhfar T, Maheshwari M, Blough ER. Biomaterials. 2015 May 8;59:160-171. doi: 10.1016/j.biomaterials.2015.04.025. [Epub ahead of print]
 
 

BAFF (B Cell Activating Factor) Transcript Level in Peripheral Blood of Patients with SLE Is Associated with Same-Day Disease Activity as Well as Global Activity over the Next Year (2015) Zollars E, Bienkowska J, Czerkowicz J, Allaire N, Ranger AM, Magder L, Petri M Lupus Science
 
 

The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Results From a Phase 3, Randomized, Placebo-Controlled Trial (PALACE 1). (2015) Schafer P, Chen P, Fang L, Wang A, Chopra R. J Immunol Res 2015 Jan 10 [Epub ahead of print]

Immune cell profiling to guide therapeutic decisions in rheumatic diseases. (2015) Ermann J, Rao DA, Teslovich NC, Brenner MB, Raychaudhuri S. Nat Rev Rheumatol. 2015 Jun 2. doi: 10.1038/nrrheum.2015.71. [Epub ahead of print]

Suppression of T Cell Activation and Collagen Accumulation by an Anti-Type I Interferon Receptor Monoclonal Antibody in Adult Patients with Systemic Sclerosis. (2015) Guo X, Higgs BW, Bay-Jensen AC, Karsdal MA, Yao Y, Roskos LK, White WI. J Invest Dermatol. 2015 May 20. doi: 10.1038/jid.2015.188. [Epub ahead of print]

Specificity of human anti-variable heavy (VH) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of TNF-a receptor 1 (2015) Cordy JC, Morley PJ, Wright TJ, Birchler MA, Lewis AP, Emmins R, Chen YZ, Powley WM, Bareille PJ, Wilson R, Tonkyn J, Bayliffe AI, Lazaar AL. Clin Exp Immunol.

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia (2015) Lee YC, Hackett J, Frits M, Iannaccone C, Shadick N, Weinblatt M, Segurado O and Sasso E Rheumatology
 
 

Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion (2015) Van Vollenhoven R, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson I, Sasso E, Hwang C, Segurado O, and Geborek P Arthritis & Rheumatol
 
 

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment (2015) Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz H-M, Nuesslein H, Alten R, Henes J, Krueger K, Schett G Ann Rheum Dis.
 
 

Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis (2015) Li W, Sasso E, van der Helm-van Mil A and Huizinga T Rheumatology
 
 

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis (2015) Reiss WG, Devenport JN, Low JM, Wu G, Sasso E Rheumatol Int
 
 

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis (2015) Michaud K, Strand V, Shadick NA, Degtiar I, Ford K, Michalopoulos SN and Hornberger J Rheumatology
 
 

Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers. (2015) Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO. Am J Respir Crit Care Med. 2015 Mar 30. [Epub ahead of print]
 
 

THU0223 Serum Biomarkers Associated with Changes in Asdas and MRI Following Treatment of Ankylosing Spondylitis with Golimumab (2015) Inman RD, Baraliakos X, Hermann KG, Braun J, Deodhar A, van der Heijde DF, Xu S, Hsu B Ann Rheum Dis

Back To Top

2014

High fidelity between saliva proteomics and the salivary glands' biological state defines biomarker-signatures for primary Sjögren's syndrome. (2014) Delaleu N, Mydel P, Kwee I, Brun JG, Jonsson MV, Jonsson R. Arthritis Rheumatol. 2014 Dec 29. doi: 10.1002/art.39015. [Epub ahead of print]
 
 

Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross sectional study (2014) Andersen, M., Boesen, M., Ellegaard, K., Christensen, R., Söderström, K., Søe, N., & Bliddal, H Arthritis Research & Therapy, 16(3), R107
 
 

Development, manufacturing and characterization of a highly purified, liquid immunoglobulin g preparation from human plasma. (2014) Laursen IA, Blou L, Sullivan JS, Bang P, Balstrup F, Houen G. Transfus Med Hemother. 2014 Jun;41(3):205-12. doi: 10.1159/000357982. Epub 2014 Apr 14.

Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. (2014) Segurado OG, Sasso EH. Clin Exp Rheumatol.
 
 

Rapid Onset Clinical and Mechanistic Effects of anti-C5aR Treatment in the Mouse Collagen Induced Arthritis Model (2014) Andersson C, Wenander CS, Usher PA, Hebsgaard JB, Sondergaard BC, Rønø B, Mackay C, Friedrichsen B, Chang C, Tang R, Hornum L Clin Exp Immunol. 2014 Mar 25
 
 

A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study (2014) Hirata S, Li W, Defranoux N, Cavet G, Bolce R, Yamaoka K, Saito K & Tanaka Y Mod Rheumatol.
 
 

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial (2014) Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank S, Sasso E, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF Ann Rheum Dis.
 
 

Back To Top

2013

IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis (2013) Wang J, Platt A, Upmanyu R, Germer S, Lei G, Rabe C, Benayed R, Kenwright A, Hemmings A, Martin M, Harari O BMJ Open. 2013 Aug 19;3(8):e003199
 
 

Suppression of soluble T cell-associated proteins by an anti-interferon-a monoclonal antibody in adult patients with dermatomyositis or polymyositis (2013) Guo X, Higgs BW, Rebelatto M, Zhu W, Greth W, Yao Y, Roskos LK, White WI Rheumatology (Oxford). 2013 Dec 19

CD47 fusion protein targets CD172a+ cells in Crohn’s disease and dampens the production of IL-1ß and TNF (2013) Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, Panzini B, Soucy G, Wassef R, Richard C, Tamaz R, Lahaie R, Bernard EJ, Caussignac Y, Leduc R, Lougnarath R, Bergeron C, Racicot MA, Bergeron F, Panzini MA, Demetter P, Franchimont D, Schäkel K, Weckbecker G, Kolbinger F, Heusser C, Huber T, Welzenbach K, Sarfati M J Exp Med. 2013 May 13. [Epub ahead of print]

Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice (2013) Peabody JW, Strand V, Shimkhada R, Lee R, Chernoff D PLoS ONE
 
 

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis (2013) Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR PLoS ONE
 
 

A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study (2013) Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga WJ and Allaart CF Rheumatology
 
 

Evaluation of Serum Biomarkers Associated with Radiographic Progression in Methotrexate-naive Rheumatoid Arthritis Patients Treated with Methotrexate or Golimumab (2013) Wagner C, Chen D, Fan H, Hsia EC, Mack M, Emery P, Fleischmann RM J Rheumatol. 2013 Mar 1. [Epub ahead of print]
 
 

Back To Top

2012

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis (2012) Eastman P.S, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK Pharm Biomed Anal.
 
 

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study (2012) Bakker MF, Cavet G, Jacobs J, Bijlsma J, Haney DJ, Shen Y, Hesterberg LK, Smith D, Centola M, van Roon J, Lafeber F, Welsing P Ann Rheum Dis.
 
 

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis (2012) Suárez-Fariñas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG J Invest Dermatol. 2012 Jul 5
 
 

Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis (2012) Zhao X, Qureshi F, Eastman P.S, Manning WC, Alexander C, Robinson WH, Hesterberg LK J Immunol Methods
 
 

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents (2012) Xu D, Kim Y, Postelnek J, Vu MD, Hu DQ, Liao C, Bradshaw M, Hsu J, Zhang J, Pashine A, Srinivasan D, Woods J, Levin A, O'Mahony A, Owens TD, Lou Y, Hill RJ, Narula S, Demartino J, Fine JS J Pharmacol Exp Ther. 2012 Apr;341(1):90-103

Interleukin-7 aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation (2012) Hartgring SA, Willis CR, Bijlsma JW, Lafeber FP, van Roon JA Arthritis Res Ther. 2012 Jun 7;14(3):R137
 
 

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab (2012) Wagner CL, Visvanathan S, Elashoff M, McInnes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M, Beutler A, Gladman D, Kavanaugh A Ann Rheum Dis. 2012 Sep 12. [Epub ahead of print]
 
 

Increased serum ß2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus (2012) Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S Lupus. 2012 May 10. [Epub ahead of print]
 
 

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis (2012) Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F Ann Rheum Dis.
 
 

Validation of a Novel Multibiomarker Test to Assess Rheumatoid Arthritis Disease Activity (2012) Curtis Jr, van der Helm-van Mil ah, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick N, Hamburger M, Fleischmann R, Keystone E, and Weinblatt ME Arthritis Care & Res.
 
 

Back To Top

2011

Modulation of Inflammatory and Lipoprotein Pathways in Skin and Serum from Patients with Psoriasis (2011) Faha NNM, Li K, Szapary PO, Krueger J, Brodmerkel C J Am Coll Cardiol; 57: 576

Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis (2011) Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R Respir Med. 2011 Nov 22. [Epub ahead of print]

Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis (2011) Hartgring SA, Willis CR, Dean CE Jr, Broere F, van Eden W, Bijlsma JW, Lafeber FP, van Roon JA Arthritis Rheum. Jul;63(7):1878-87

Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis (2011) Baker JF, George M, Baker DG, Toedter G, Von Feldt JM, Leonard MB Rheumatology (Oxford). 2011 Sep 2. [Epub ahead of print]
 
 

Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE (2011) Kovalchin J, Krieger J, Genova M, Kawamoto N, Augustyniak M, Collins K, Bloom T, Masci A, Hittinger T, Dufour I, Strominger JL, Zanelli E PLoS ONE 6(12): e26274
 
 

Back To Top

2010

Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study (2010) Visvanathan S, Rahman MU, Keystone E, Genovese M, Klareskog L, Hsia E, Mack M, Buchanan J, Elashoff M, Wagner C Arthritis Res Ther. 12:R211
 
 

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis (2010) Woo JM, Lin Z, Navab M, Van Dyck C, Trejo-Lopez Y, Woo KM, Li H, Castellani LW, Wang X, Iikuni N, Rullo OJ, Wu H, La Cava A, Fogelman AM, Lusis AJ, Tsao BP Arthritis Res Ther 12: R93.

Back To Top

2008

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. (2008) Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA, Chen G, Breen P, Buckner JH, Molitor JA, Elkon KB, Schwartz SM Arthritis Rheum 58: 1465-1474.
 
 

Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. (2008) Torrence AE, Brabb T, Viney JL, Bielefeldt-Ohmann H, Treuting P, Seamons A, Drivdahl R, Zeng W, Maggio-Price L Inflamm Bowel Dis 14: 480-490.

Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. (2008) Delaleu N, Immervoll H, Cornelius J, Jonsson R Arthritis Res Ther 10: R22.
 
 

Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460 (2008) Delaleu N, Madureira AC, Immervoll H, Jonsson R Arthritis Rheum. Aug;58(8):2318-28
 
 

Back To Top

2006

Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. (2006) Schilling S, Goelz S, Linker R, Luehder F, Gold R Clin Exp Immunol 145: 101-117.

TWEAK is a novel arthritogenic mediator. (2006) Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, Su L, Tarilonte L, Crowell T, Rajman L, Runkel L, Scott M, Atkins GJ, Findlay DM, Zheng TS, Hess H J Immunol 177: 2610-2620.
 
 

Cutting edge: interleukin 17 signals through a heteromeric receptor complex. (2006) Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, Tocker J, Peschon J J Immunol 177: 36-39.
 
 

Back To Top

2005

Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis. (2005) Kliwinski C, Kukral D, Postelnek J, Krishnan B, Killar L, Lewin A, Nadler S, Townsend R J Autoimmun 25: 165-171.